Sutro Biopharma, Inc.STRONASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-140.64%
↓ 34% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-105.34%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -140.64% | +51.6% |
| 2024 | -290.85% | -558.4% |
| 2023 | -44.18% | +71.5% |
| 2022 | -155.03% | +1.7% |
| 2021 | -157.66% | -183.5% |
| 2020 | -55.60% | +49.0% |
| 2019 | -109.08% | -27.7% |
| 2018 | -85.42% | -213.8% |
| 2017 | -27.22% | -320.8% |
| 2016 | 12.33% | - |